Tianjin Hemu Jianmin Biotechnology Co., Ltd

China

Back to Profile
1-3 of 3 for Tianjin Hemu Jianmin Biotechnology Co., Ltd Sort by
Query
Aggregations
Date
2020 1
Before 2020 2
IPC Class
A61K 39/00 - Medicinal preparations containing antigens or antibodies 3
A61K 39/29 - Hepatitis virus 3
A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants 3
C12R 1/78 - Hansenula 3
A61P 31/20 - Antivirals for DNA viruses 2
See more
Found results for  patents

1.

Hepatitis B treatment vaccine base on inactivated whole recombinant Hansenula polymorpha cells which expresses HBsAg and HBcAg

      
Application Number 16088217
Grant Number 11191829
Status In Force
Filing Date 2017-03-16
First Publication Date 2020-12-03
Grant Date 2021-12-07
Owner TIANJIN HEMU JIANMIN BIOTECHNOLOGY CO., LTD (China)
Inventor
  • Wang, Hemu
  • Wang, Changhua
  • Yang, Jun

Abstract

Hansenula polymorpha cell is used as an adjuvant.

IPC Classes  ?

  • A61K 39/29 - Hepatitis virus
  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • C12N 1/16 - YeastsCulture media therefor
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • C12R 1/78 - Hansenula

2.

Hepatitis B treatment vaccine on the basis of inactivated, whole recombinant Hansenula polymorpha cells expressing HBsAg

      
Application Number 16088169
Grant Number 10653772
Status In Force
Filing Date 2017-03-16
First Publication Date 2019-07-18
Grant Date 2020-05-19
Owner TIANJIN HEMU JIANMIN BIOTECHNOLOGY CO., LTD (China)
Inventor
  • Wang, Hemu
  • Wang, Changhua
  • Yang, Jun

Abstract

Hansenula polymorpha cells as an adjuvant.

IPC Classes  ?

  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • C07K 14/02 - Hepadnaviridae, e.g. hepatitis B virus
  • A61K 47/46 - Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
  • C07K 14/005 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from viruses
  • A61K 36/06 - Fungi, e.g. yeasts
  • A61K 39/29 - Hepatitis virus
  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • A61P 31/20 - Antivirals for DNA viruses
  • C12N 7/00 - Viruses, e.g. bacteriophagesCompositions thereofPreparation or purification thereof
  • C12R 1/78 - Hansenula

3.

Recombinant Hansenula polymorpha-based high dosage hepatitis B vaccine

      
Application Number 16088255
Grant Number 10821174
Status In Force
Filing Date 2017-03-16
First Publication Date 2019-03-21
Grant Date 2020-11-03
Owner TIANJIN HEMU JIANMIN BIOTECHNOLOGY CO., LTD (China)
Inventor
  • Wang, Hemu
  • Wang, Changhua
  • Yang, Jun

Abstract

Hansenula polymorpha fermentation broth used for producing the hepatitis B vaccine being 300 mg/L-400 mg/L.

IPC Classes  ?

  • A61K 39/29 - Hepatitis virus
  • C12N 9/88 - Lyases (4.)
  • A61K 39/12 - Viral antigens
  • A61P 31/20 - Antivirals for DNA viruses
  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • C07K 14/02 - Hepadnaviridae, e.g. hepatitis B virus
  • C12R 1/78 - Hansenula
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies